SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-001745
Filing Date
2021-09-09
Accepted
2021-09-09 17:01:13
Documents
12
Period of Report
2021-09-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K janx-20210907.htm   iXBRL 8-K 55385
  Complete submission text file 0000950170-21-001745.txt   189508

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT janx-20210907_lab.xml EX-101.LAB 20194
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT janx-20210907.xsd EX-101.SCH 2506
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT janx-20210907_pre.xml EX-101.PRE 12166
5 EXTRACTED XBRL INSTANCE DOCUMENT janx-20210907_htm.xml XML 5116
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40475 | Film No.: 211245051
SIC: 2834 Pharmaceutical Preparations